Project Details
Description
Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of fulvestrant (faslodex) with or without PD-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive,
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/13 → 1/31/21 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.